Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	651,800	506,943	267,413	293,942	446,056	548,450
Market Cap Growth	102.77%	89.57%	-9.03%	-34.10%	-18.67%	-36.13%
Enterprise Value	667,103	522,408	289,788	324,970	476,056	565,527
Last Close Price	9010.00	7020.00	3860.00	4190.00	6350.57	7804.20
PE Ratio	-	-	20.39	-	-	-
PS Ratio	12.42	9.66	4.55	6.89	11.21	15.30
PB Ratio	9.05	7.04	4.08	4.90	6.80	7.58
P/TBV Ratio	9.61	7.47	4.43	5.22	7.36	8.26
P/FCF Ratio	-	-	34.28	-	-	-
P/OCF Ratio	-	-	30.23	-	-	-
EV/Sales Ratio	12.72	9.96	4.93	7.62	11.96	15.78
EV/EBITDA Ratio	139.02	108.86	31.18	-	21308.58	-
EV/EBIT Ratio	-	266.47	46.79	-	-	-
EV/FCF Ratio	-179.88	-	37.14	-	-	-
Debt / Equity Ratio	0.56	0.56	0.67	0.75	0.58	0.46
Debt / EBITDA Ratio	8.48	8.48	4.72	-	1706.78	-
Debt / FCF Ratio	-	-	5.62	-	-	-
Net Debt / Equity Ratio	0.18	0.18	0.33	0.51	0.42	0.27
Net Debt / EBITDA Ratio	2.66	2.66	2.30	-11.04	1223.16	-11.41
Net Debt / FCF Ratio	-3.45	-3.45	2.74	-8.81	-10.29	-9.42
Asset Turnover	0.41	0.41	0.49	0.37	0.35	0.30
Inventory Turnover	2.39	2.39	2.52	1.93	1.87	1.77
Quick Ratio	0.86	0.86	0.83	0.52	0.53	0.93
Current Ratio	1.30	1.30	1.30	0.96	1.01	1.61
Return on Equity (ROE)	-11.67%	-11.67%	23.40%	-9.41%	-10.84%	-7.89%
Return on Assets (ROA)	0.95%	0.95%	3.21%	-3.40%	-2.09%	-2.79%
Return on Capital Employed (ROCE)	2.40%	2.40%	8.10%	-9.50%	-5.40%	-5.90%
Earnings Yield	-1.11%	-1.42%	4.90%	-1.35%	-1.46%	-0.81%
FCF Yield	-0.57%	-0.73%	2.92%	-1.17%	-0.60%	-0.38%
Buyback Yield / Dilution	-1.32%	-1.32%	0.57%	0.18%	-0.01%	-0.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.